Hims & Hers Health (HIMS) Earnings Date, Estimates & Call Transcripts → Millionaire investor and Republican donor makes surprising election prediction (From InvestorPlace) (Ad) Free HIMS Stock Alerts $12.80 +0.51 (+4.15%) (As of 03:34 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 5EstimatedActual EPS (May. 6) $0.05 Beat By $0.03 Consensus EPS (May. 6) $0.02 Read Call TranscriptListen to Call Get Hims & Hers Health Earnings AlertsEnter your email address below to receive the latest news and earnings results for HIMS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueHIMS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.HIMS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Huge AlertsThis 1 Biotech Stock has been shocking the marketsSave the Date: BioStem's 2024 Q1 Call Coming Up!Sign Up for the Live Broadcast here Hims & Hers Health Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242($0.02)$0.02$0.00 Q2 20243($0.03)$0.05$0.02 Q3 20242($0.03)$0.05$0.01 Q4 20242($0.04)$0.03($0.01) FY 20249($0.12)$0.15 $0.03HIMS Earnings Date and InformationHims & Hers Health last released its earnings data on May 6th, 2024. The reported $0.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.02 by $0.03. The company had revenue of $278.20 million for the quarter, compared to analyst estimates of $270.37 million. Its quarterly revenue was up 45.8% on a year-over-year basis. Hims & Hers Health has generated ($0.01) earnings per share over the last year (($0.01) diluted earnings per share). Earnings for Hims & Hers Health are expected to grow by 77.78% in the coming year, from $0.18 to $0.32 per share. Hims & Hers Health has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off prior year's report dates.Read More Hims & Hers Health Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/5/2024Estimated)------- 5/6/2024Q1 2024$0.02$0.05+$0.03$0.05$270.37 million$278.20 million 2/26/2024Q4 2023($0.02)$0.01+$0.03$0.01$245.84 million$246.60 million 11/6/2023Q3 2023($0.03)($0.04)($0.01)($0.04)$220.08 million$226.70 million 8/7/2023Q2 2023($0.06)($0.03)+$0.03($0.03)$204.95 million$207.91 million 5/8/2023Q1 2023($0.06)($0.05)+$0.01($0.05)$179.07 million$190.80 million 2/27/2023Q4 2022($0.07)($0.05)+$0.02($0.05)$161.18 million$167.30 million Get the Latest News and Ratings for HIMS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter. 11/7/2022Q3 2022($0.11)($0.09)+$0.02($0.09)$130.32 million$144.84 million8/8/2022Q2 2022($0.10)($0.10)-($0.10)$103.89 million$113.60 million 5/9/2022Q1 2022($0.09)($0.08)+$0.01($0.08)$90.99 million$101.30 million 2/22/2022Q4 2021($0.10)($0.11)($0.01)($0.07)$76.79 million$84.70 million 11/10/2021Q3 2021($0.14)($0.09)+$0.05($0.10)$70.10 million$74.17 million 8/11/2021Q2 2021($0.16)($0.08)+$0.08($0.11)$55.94 million$60.69 million5/17/2021Q1 2021($0.15)($0.14)+$0.01$0.06$48.74 million$52.31 million Hims & Hers Health Earnings - Frequently Asked Questions When is Hims & Hers Health's earnings date? Hims & Hers Health has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off last year's report dates. Learn more on HIMS's earnings history. Did Hims & Hers Health beat their earnings estimates last quarter? In the previous quarter, Hims & Hers Health (NYSE:HIMS) reported $0.05 earnings per share (EPS) to beat the analysts' consensus estimate of $0.02 by $0.03. Learn more on analysts' earnings estimate vs. HIMS's actual earnings. How can I listen to Hims & Hers Health's earnings conference call? The conference call for Hims & Hers Health's latest earnings report can be listened to online. Listen to Conference Call How can I read Hims & Hers Health's conference call transcript? The conference call transcript for Hims & Hers Health's latest earnings report can be read online. Read Transcript How much revenue does Hims & Hers Health generate each year? Hims & Hers Health (NYSE:HIMS) has a recorded annual revenue of $872 million. How much profit does Hims & Hers Health generate each year? Hims & Hers Health (NYSE:HIMS) has a recorded net income of -$23.55 million. HIMS has generated -$0.01 earnings per share over the last four quarters. What is Hims & Hers Health's EPS forecast for next year? Hims & Hers Health's earnings are expected to grow from $0.18 per share to $0.32 per share in the next year, which is a 77.78% increase. More Earnings Resources from MarketBeat Related Companies: Teladoc Health Earnings TG Therapeutics Earnings LifeStance Health Group Earnings Neogen Earnings MorphoSys Earnings Bausch Health Companies Earnings Corcept Therapeutics Earnings Twist Bioscience Earnings MoonLake Immunotherapeutics Earnings Arcellx Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NYSE:HIMS) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThis 1 Biotech Stock has been shocking the marketsHuge AlertsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
